A detailed history of Headlands Technologies LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 19,345 shares of ARVN stock, worth $357,495. This represents 0.06% of its overall portfolio holdings.

Number of Shares
19,345
Previous 16,837 14.9%
Holding current value
$357,495
Previous $448,000 6.25%
% of portfolio
0.06%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.66 - $32.73 $59,339 - $82,086
2,508 Added 14.9%
19,345 $476,000
Q2 2024

Aug 07, 2024

BUY
$24.46 - $40.4 $411,833 - $680,214
16,837 New
16,837 $448,000
Q4 2023

Feb 02, 2024

BUY
$14.19 - $42.33 $27,017 - $80,596
1,904 Added 393.39%
2,388 $98,000
Q3 2023

Nov 09, 2023

BUY
$19.64 - $28.21 $9,505 - $13,653
484 New
484 $9,000
Q1 2023

May 01, 2023

BUY
$26.15 - $37.26 $1,359 - $1,937
52 New
52 $1,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $983M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.